Bafna Pharmaceuticals zooms on getting UK-MHRA approval for packaging lines

04 May 2021 Evaluate

Bafna Pharmaceuticals is currently trading at Rs. 135.15, up by 6.40 points or 4.97% from its previous closing of Rs. 128.75 on the BSE.

The scrip opened at Rs. 135.15 and has touched a high and low of Rs. 135.15 and Rs. 135.15 respectively. So far 4047 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 195.95 on 23-Mar-2021 and a 52 week low of Rs. 10.24 on 27-Jul-2020.

Last one week high and low of the scrip stood at Rs. 137.90 and Rs. 123.80 respectively. The current market cap of the company is Rs. 319.72 crore.

The promoters holding in the company stood at 91.74%, while Non-Institutions held 8.26%.

Bafna Pharmaceuticals has added two fully automated packaging lines to its existing capacity and they have been approved by the UK-MHRA (Medicines and Healthcare products Regulatory Agency) for the United Kingdom and the European Union (EU). This approval will enable the company to increase its output and consequentially generate higher revenue and profits.

Bafna Pharmaceuticals is engaged in the business of manufacturing of finished pharmaceutical formulations.

Bafna Pharma Share Price

94.77 -4.98 (-4.99%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.